In other words, the price has increased by $0.0000 from its previous closing price. On the day, 1123918 shares were traded. ACIU stock price reached its highest trading level at $2.8400 during the session, while it also had its lowest trading level at $2.7240.
Ratios:
For a deeper understanding of AC Immune SA’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.22 and its Current Ratio is at 9.22. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On April 05, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $18.H.C. Wainwright initiated its Buy rating on April 05, 2018, with a $18 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACIU now has a Market Capitalization of 271.97M and an Enterprise Value of 161.56M. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.35 while its Price-to-Book (P/B) ratio in mrq is 1.43. Its current Enterprise Value per Revenue stands at 10.92 whereas that against EBITDA is -3.12.
Stock Price History:
Over the past 52 weeks, ACIU has reached a high of $5.14, while it has fallen to a 52-week low of $1.78. The 50-Day Moving Average of the stock is 3.2470, while the 200-Day Moving Average is calculated to be 3.2355.
Shares Statistics:
For the past three months, ACIU has traded an average of 145.88K shares per day and 347.33k over the past ten days. A total of 99.20M shares are outstanding, with a floating share count of 57.09M. Insiders hold about 42.45% of the company’s shares, while institutions hold 30.59% stake in the company. Shares short for ACIU as of Mar 15, 2024 were 582.97k with a Short Ratio of 4.00, compared to 668.08k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.59% and a Short% of Float of 1.10%.
Earnings Estimates
There are 2 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.19, while EPS last year was -$0.23. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.2 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.71 and -$0.72 for the fiscal current year, implying an average EPS of -$0.72. EPS for the following year is -$0.07, with 2 analysts recommending between $0.41 and -$0.55.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for ACIU’s current fiscal year. The highest revenue estimate was $16.96M, while the lowest revenue estimate was $11.09M, resulting in an average revenue estimate of $14.02M. In the same quarter a year ago, actual revenue was $16.42M, down -14.60% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $89.6M in the next fiscal year. The high estimate is $150.8M and the low estimate is $28.4M. The average revenue growth estimate for next year is up 539.10% from the average revenue estimate for this year.
